Allogeneic stem cell transplantation and combination antiretroviral therapy: cautions, complications, and considerations. Leuk Lymphoma. 2019:1-4..
CAR-T cell manufacture: snatching victory when defeat is looming. Transfusion. 2018;58(6):1335-1337..
Clinical characteristics and outcomes of COVID-19 in haematopoietic stem-cell transplantation recipients: an observational cohort study. Lancet Haematol. 2021.
Finding the value of allogeneic stem cell transplantation for lower-risk myelodysplastic syndromes. Expert Rev Hematol. 2020..
Hypomethylating agents and FLT3 inhibitors as maintenance treatment for acute myeloid leukemia and myelodysplastic syndrome following allogeneic hematopoietic stem cell transplant - a systematic review and meta-analysis. Transplant Cell Ther. 2021.
The Impact of a Multimodal Approach to Vancomycin Discontinuation in Hematopoietic Stem Cell Transplant Recipients (HSCT) with Febrile Neutropenia (FN). Transpl Infect Dis. 2019:e13059..
Outcomes of Allogeneic Hematopoietic Cell Transplantation in T-cell Prolymphocytic Leukemia: A Contemporary Analysis from the Center for International Blood and Marrow Transplant Research. Transplant Cell Ther. 2022.
Primary plasma cell leukemia: autologous stem cell transplant in an era of novel induction drugs. Bone Marrow Transplant. 2018.